beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy

Yazar
Frelih, Nina
Boni, Elisa
Bozek, Andrzej
Chelminska, Marta
Ernst, Barbara
Gawlik, Radoslaw
Hawranek, Thomas
Hoetzenecker, Wolfram
Jimenez Blanco, Aranzazu
Kita, Karolina
Kendirlinan, Resat
Kosnik, Mitja
Laipold, Karin
Lang, Roland
Marchi, Francesco
Mauro, Marina
Nittner-Marszalska, Marita
Poziomkowska-Gesicka, Iwona
Pravettoni, Valerio
Preziosi, Donatella
Quercia, Oliviero
Reider, Norbert
Rosiek-Biegus, Marta
Ruiz-Leon, Berta
Schrautzer, Christoph
Serrano, Pilar
Sin, Aytul
SİN, BETÜL AYŞE
Stoevesandt, Johanna
Trautmann, Axel
Vachova, Martina
Arzt-Gradwohl, Lisa
Gelincik, Asli
Sturm, Gunter Johannes
Herzog, Sereina Annik
Aberer, Werner
Alfaya Arias, Teresa
Antolin-Amerigo, Dario
Bonadonna, Patrizia
Üst veri
Tüm öğe kaydını göster
Özet
Background There is controversy whether taking beta-blockers or ACE inhibitors (ACEI) is a risk factor for more severe systemic insect sting reactions (SSR) and whether it increases the number or severity of adverse events (AE) during venom immunotherapy (VIT).
Bağlantı
http://hdl.handle.net/20.500.12627/172105
https://doi.org/10.1111/all.14785
Koleksiyonlar